Saudi Chemical Holding Company
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Saudi Chemical Holding Company's yearly results (2022–2025), compared with Healthcare companies in Saudi Arabia. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every SAR 100 of net worth, SAR 74 is tangible; the rest is goodwill and other intangibles, often from buying other companies. Less tangible than 95% of Healthcare companies in Saudi Arabia.
- Tangible Assets Ratio: Of every SAR 100 the company owns, SAR 90 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 95% of Healthcare companies in Saudi Arabia.
- Profit Cash Ratio: Over the last 3 years, every SAR 100 of reported profit came with SAR 82 of operating cash. Lower than 88% of Healthcare companies in Saudi Arabia.
Where SAR 100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
SAR 82Over the last 3 years, every SAR 100 of reported profit came with SAR 82 of operating cash.
Lower than 88% of Healthcare companies in Saudi Arabia.
Self-Funding Ratio
4.5×Over the last 3 years its own operating cash covered its investment spending (capex) 4.5 times.
Higher than 79% of Healthcare companies in Saudi Arabia.
Cash Locked Ratio
SAR 27For every SAR 100 of sales, SAR 27 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against SAR 36 tied up three years earlier.
Less money tied up than 54% of Healthcare companies in Saudi Arabia.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 75% of Healthcare companies in Saudi Arabia.
Growth Efficiency Ratio
SAR 8Sales grew 86% in 3 years; of every extra SAR 100 of sales, SAR 8 became extra profit.
Lower than 62% of Healthcare companies in Saudi Arabia.
Asset Productivity Ratio
+86% / +34%In 3 years sales changed by +86% while total assets changed by +34%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
0.7×Debt due within a year is covered 0.7 times by its yearly operating cash.
Lower than 62% of Healthcare companies in Saudi Arabia.
Cash Cushion Ratio
−21%Debt, after subtracting cash, equals 21% of its market value (net debt).
Lower than 54% of Healthcare companies in Saudi Arabia.
Tangible Assets Ratio
90%Of every SAR 100 the company owns, SAR 90 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 95% of Healthcare companies in Saudi Arabia.
Tangible Net Worth Ratio
74%Of every SAR 100 of net worth, SAR 74 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 95% of Healthcare companies in Saudi Arabia.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Saudi Chemical Holding Company owes SAR 0.60 for every SAR 1 it owns. Net profit rose 15% in the year to Dec 2025, and grew 61% a year on average over 3 years.
Compared with Healthcare companies in Saudi Arabia · latest annual results Dec 2025.
P/E ratio
14.3Investors pay SAR 14.3 for every SAR 1 of Saudi Chemical Holding Company's yearly profit, lower than 79% of Healthcare companies in Saudi Arabia.
P/B ratio
2.05The share price is 2.05 times Saudi Chemical Holding Company's book value per share, lower than 54% of Healthcare companies in Saudi Arabia.
Market cap
SAR 5.1 BThe total market value of all of Saudi Chemical Holding Company's shares at today's price (share price × number of shares), larger than 54% of Healthcare companies in Saudi Arabia. PosiCap size class: Meso Cap.
Net worth (book value)
SAR 2.5 BWhat Saudi Chemical Holding Company would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
SAR 2.92Net worth divided by the number of shares. The share price of SAR 6.00 is 2.1 times this, which is the P/B above.
Return on equity (ROE)
15.1%Saudi Chemical Holding Company earned 15.1% on its shareholders' money over the last year, higher than 50% of Healthcare companies in Saudi Arabia.
Owes vs Owns
0.60×Saudi Chemical Holding Company owes SAR 0.60 for every SAR 1 it owns (moderate), higher than 62% of Healthcare companies in Saudi Arabia.
Dividend yield
1.83%Saudi Chemical Holding Company pays 1.83% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in Saudi Arabia.
Revenue growth
+8%Revenue rose 8% in the year to Dec 2025, and grew 23% a year on average over 3 years.
Profit growth
+15%Net profit rose 15% in the year to Dec 2025, and grew 61% a year on average over 3 years.
Profit margin
4.9%Saudi Chemical Holding Company keeps SAR 5 of every SAR 100 of revenue as net profit.
Cash quality
1.5×Cash from Saudi Chemical Holding Company's business was 1.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
4.9×Saudi Chemical Holding Company's operating profit covered its interest costs 4.9 times in the year to Dec 2025.
Cash vs debt
Net debtSaudi Chemical Holding Company had SAR 1.1 B more debt than cash (net debt) at Dec 2025.
Questions
What is Saudi Chemical Holding Company's P/E ratio?
Investors pay SAR 14.3 for every SAR 1 of Saudi Chemical Holding Company's yearly profit, lower than 79% of Healthcare companies in Saudi Arabia.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Saudi Chemical Holding Company: SAR 5.1 B ÷ SAR 2.5 B (30 Jun 2026) = 2.1.
What is Saudi Chemical Holding Company's return on equity?
Saudi Chemical Holding Company earned 15.1% on its shareholders' money over the last year, higher than 50% of Healthcare companies in Saudi Arabia.
How much does Saudi Chemical Holding Company owe compared with what it owns?
Saudi Chemical Holding Company owes SAR 0.60 for every SAR 1 it owns (moderate), higher than 62% of Healthcare companies in Saudi Arabia.
Does Saudi Chemical Holding Company pay a dividend?
Yes. Saudi Chemical Holding Company pays 1.83% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in Saudi Arabia.
Is Saudi Chemical Holding Company's revenue growing?
Revenue rose 8% in the year to Dec 2025, and grew 23% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.